Kevin A. Camphausen, M.D.
Radiation Oncology Branch
Head, Imaging and Molecular Therapeutics Section
Branch Chief
National Cancer Institute
9000 Rockville Pike
Building 10, Room B2-3561
Bethesda, MD 20892
Phone: 301-496-5457
Fax: 301-480-5439
camphauk@mail.nih.gov
Dr. Camphausen received his M.D. from Georgetown University in 1996. He completed his internship at Georgetown in 1997 and a residency in radiation oncology at the Joint Center for Radiation Therapy at Harvard Medical School in 2001. Dr. Camphausen spent two years working in the laboratory of Dr. Judah Folkman studying the interaction of angiogenesis inhibitors and radiotherapy. He joined the National Cancer Institute in July 2001 as a tenure-track investigator. He served as the deputy branch chief beginning in April 2004 and was appointed to branch chief of the Radiation Oncology Branch in 2008. Dr. Camphausen is board certified by the American Board of Radiology.
Dr. Camphausen's Clinical Trial(s):
NCI’s Center for Cancer Research (CCR) is currently conducting the following trial(s) for patients with brain tumors. Click on the trial(s) below for additional details, including a summary of key eligibility criteria, study outline, and information on how to contact the study team directly.
The quality of these videocasts is dependent on the speed of your Internet connection. Many videocasts are streamed directly to your computer by software on the NIH VideoCasting Web site. Others require that you have a standalone player installed on your computer to handle the streaming. If you do not have a standalone player installed or if you are having problems viewing the videocast, please visit http://videocast.nih.gov/faq/.
|
CC Grand Rounds: (1) From Genes to Targets in Thoracic Malignancies (2) HDAC Inhibitors as Radiation Modifiers: From Bench to Clinic Speaker(s): Giuseppe Giaccone, M.D., Ph.D., Chief, Medical Oncology Branch, NCI April 21, 2010 55 minutes http://videocast.nih.gov/Summary.asp?File=15828 |
Some of the resources above require the use of a standalone player: Download Free RealPlayer 
Back to Top
Clinical Trials Research
Imaging and Molecular Therapeutics Section:
It is predicted that there will be 1.2 million non-skin cancers diagnosed in North America in 2006; seventy-five percent of these (i.e., 900,000 cancer patients) will receive radiotherapy sometime during the course of their disease. Improving the efficacy of radiotherapy would significantly contribute to cancer treatment in general given its pervasiveness as an anti-neoplastic therapy.
Read more
 | Watch/Listen to Dr. Camphausen's videocast/podcast |
